Troubleshooting Guide: Solving False Positives in CRISPR-Cas12a Lateral Flow Assays

Introduction

CRISPR-Cas12a diagnostics have revolutionized nucleic acid detection, offering sensitivity comparable to PCR with the simplicity of a lateral flow readout. However, a common challenge frustrates researchers worldwide: false positives. In this guide, we explore why background signals occur in CRISPR lateral flow assays and how Due Bio’s Universal Strips help mitigate these issues through optimized membrane chemistry.

Why Do False Positives Occur?

False positives in CRISPR-Cas12a systems typically stem from three main sources:

  1. Reporter Leakage: Uncleaved ssDNA reporters may partially hybridize or interact non-specifically with the test line.
  2. Buffer Incompatibility: High salt concentrations or incorrect pH can trigger non-specific aggregation of gold nanoparticles (AuNPs).
  3. Nuclease Contamination: RNase or DNase contamination in the workspace can degrade reporters prematurely.

The Role of Strip Quality

Not all lateral flow strips are created equal. Recent studies (including Biosensors 2025) highlight that membrane blocking and conjugate pad treatment are critical. Due Bio’s Tiosbio® strips utilize a proprietary blocking buffer that minimizes non-specific binding of the FAM-Biotin reporter, significantly improving signal-to-noise ratios.

CRISPR Lateral Flow Workflow reducing false positives

3 Steps to Cleaner Results

  • Titrate Your Reporter: Excessive reporter concentration (>500 nM) often leads to background. We recommend starting at 100-200 nM.
  • Optimize Run Buffer: Ensure your running buffer contains adequate surfactant (e.g., 1% Tween-20) to facilitate smooth flow.
  • Use Validated Strips: Switch to Due Bio Universal Strips, quality-controlled for CRISPR applications.

Ready to improve your assay sensitivity? Contact our technical team for a free sample pack.

Leave a Comment